Identifying responders before treatment could improve outcomes and reduce failed treatment attempts
Your provider sets your starting dose and a gradual step-up plan, personalized to you and documented in your patient portal
TB-500 is commonly described as a synthetic fragment related to thymosin beta-4, but online claims about TB-500 should not be assumed to match the full body of thymosin beta-4 research
Planta 231, 609621 (2010)
The separation was performed on an Easy-Spray PepMap RSLC C18 analytical column (75 m 50 cm, Thermo Scientific) under gradient conditions starting with 2% Buffer B, held for 5 min, followed by a linear increase to 35% Buffer B over 125 min, reaching 98% Buffer B after a further 2 min, and maintained for 10 min, before re-equilibration to 35% Buffer B after 1 min
1.5 % Total impurities: max